Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:310359.
doi: 10.1155/2012/310359. Epub 2012 Oct 22.

Medulloblastoma with excessive nodularity: radiographic features and pathologic correlate

Affiliations

Medulloblastoma with excessive nodularity: radiographic features and pathologic correlate

L A Yeh-Nayre et al. Case Rep Radiol. 2012.

Abstract

Medulloblastoma with extensive nodularity is a rare subtype of the most common malignant childhood brain tumor and has been associated with more favorable prognosis. The authors report the case of a 10-month-old girl with a posterior fossa tumor of excessive nodularity with decreased diffusivity on diffusion-weighted magnetic resonance imaging sequences and robust grape-like postgadolinium contrast enhancing features. The unique neuroradiographic features were confirmed by histopathology and a diagnosis of medulloblastoma with extensive nodularity was made. This case highlights the importance of recognizing this unique medulloblastoma subtype preoperatively, as the more favorable outcome may preclude less aggressive medical management.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MRI features of medulloblastoma with extensive nodularity: (a)–(c) axial sequences reveal a posterior fossa mass (arrows) with decreased diffusivity on DWI (a) and ADC sequences (b), without specific intratumoral abnormalities on SWI sequence aside from amorphous susceptibility artifact present along the vermis from prior surgical biopsy (c). Sagittal sequences reveal extensive nodularity on T2 (d) and postgadolinium (f) sequences that is less evidence on precontrast T1-weighted sequences where the nodular areas appear more hypointense (e).
Figure 2
Figure 2
Histologic features of medulloblastoma with extensive nodularity. Hematoxilin and eosin section (4 μm; 100x) reveals a malignant small blue cell tumor with widespread formation of nodules of uniform cells with neuropil formation surrounded by intervening areas of more densely populated pleomorphic cells consistent with a diagnosis of medulloblastoma with extensive nodularity. The arrowheads point to the nodular zones.

Similar articles

Cited by

  • Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance.
    Nguyen NM, Cho J. Nguyen NM, et al. Int J Mol Sci. 2022 Feb 3;23(3):1733. doi: 10.3390/ijms23031733. Int J Mol Sci. 2022. PMID: 35163655 Free PMC article. Review.
  • Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
    Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P, Bender S, Schmidt C, Rausch T, Shih D, Reimand J, Sieber L, Wittmann A, Linke L, Witt H, Weber UD, Zapatka M, König R, Beroukhim R, Bergthold G, van Sluis P, Volckmann R, Koster J, Versteeg R, Schmidt S, Wolf S, Lawerenz C, Bartholomae CC, von Kalle C, Unterberg A, Herold-Mende C, Hofer S, Kulozik AE, von Deimling A, Scheurlen W, Felsberg J, Reifenberger G, Hasselblatt M, Crawford JR, Grant GA, Jabado N, Perry A, Cowdrey C, Croul S, Zadeh G, Korbel JO, Doz F, Delattre O, Bader GD, McCabe MG, Collins VP, Kieran MW, Cho YJ, Pomeroy SL, Witt O, Brors B, Taylor MD, Schüller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM; ICGC PedBrain Tumor Project. Kool M, et al. Cancer Cell. 2014 Mar 17;25(3):393-405. doi: 10.1016/j.ccr.2014.02.004. Cancer Cell. 2014. PMID: 24651015 Free PMC article.
  • Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage.
    Ghasemi DR, Okonechnikov K, Rademacher A, Tirier S, Maass KK, Schumacher H, Joshi P, Gold MP, Sundheimer J, Statz B, Rifaioglu AS, Bauer K, Schumacher S, Bortolomeazzi M, Giangaspero F, Ernst KJ, Clifford SC, Saez-Rodriguez J, Jones DTW, Kawauchi D, Fraenkel E, Mallm JP, Rippe K, Korshunov A, Pfister SM, Pajtler KW. Ghasemi DR, et al. Nat Commun. 2024 Jan 8;15(1):269. doi: 10.1038/s41467-023-44117-x. Nat Commun. 2024. PMID: 38191550 Free PMC article.

References

    1. CBTRUS. CBTRUS Statistical Report. Hindsdale, Ill, USA: Central Brain Tumor Registry of the United States; 2012. Primary brain and central nervous system tumors diagnosed in the United States in 2004–2008.
    1. Kool M, Korshunov A, Remke M, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathologica. 2012;123:473–484. - PMC - PubMed
    1. Cho YJ, Tsherniak A, Tamayo P, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. Journal of Clinical Oncology. 2011;29(11):1424–1430. - PMC - PubMed
    1. Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants. Journal of Clinical Oncology. 2011;29(11):1408–1414. - PMC - PubMed
    1. Kool M, Koster J, Bunt J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE. 2008;3(8)e3088 - PMC - PubMed

LinkOut - more resources